Acquiring Company
Hena Holdings
Acquired Company
Integrated Diagnostics Holdings
British Virgin Islands
EgyptBiotechnologyHealth CareMedicalMedical DeviceBiotechnologyHealth CareMedicalDescription
Hena Holdings has successfully acquired Integrated Diagnostics Holdings, facilitating a take-private transaction valued at approximately $290.7 million. The acquisition was financed through a $60 million loan and equity commitments from Hena's leaders. Following the deal, Hena will have a controlling stake, taking the company private and restructuring its ownership. Integrated Diagnostics has shown significant growth, with strong revenue increases reported recently.
Don't miss Hena Holdings's next move
Get an email the moment Hena Holdings makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Integrated Diagnostics Holdings?
Integrated Diagnostics Holdings was acquired by Hena Holdings, based in British Virgin Islands. The deal was reported on August 28, 2026. Hena Holdings is a private company incorporated in the British Virgin Islands. It is co-owned by two women and is focused on acquiring medical testing firms in Egypt. Hena Holdings is privately held and operates in Biotechnology.
When did Hena Holdings acquire Integrated Diagnostics Holdings?
Hena Holdings's acquisition of Integrated Diagnostics Holdings was reported on August 28, 2026. Hena Holdings has successfully acquired Integrated Diagnostics Holdings, facilitating a take-private transaction valued at approximately $290.7 million. The acquisition was financed through a $60 million loan and equity commitments from Hena's leaders. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Integrated Diagnostics Holdings do?
Integrated Diagnostics Holdings is an Egyptian medical testing group that began operations in 1979. It has expanded across the Middle East and Africa, running 628 branches and serving approximately 9 million patients annually. It is privately held, operating in Biotechnology, and is based in Egypt.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.